Do you want to read an article? Please log in or register.
Lung cancer screening care pathways in community settings: An examination of three healthcare systems
Lung Cancer
Related content
RECOMMENDED
Lung Cancer
Quality Implementation of Lung Cancer Screening System (QUILS™ 1.0): A system to support high-quality delivery of lung cancer screening in diverse settings
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Chest
Studts JL, Knight JR, Yates AR, Alexander JL, Damron KJ, Barry AM, Studts CR, Brooks MT, Mullett TW
doi: 10.1016/j.chest.2025.10.050
Lung Cancer
THE IMPACT OF THE 2023 ACS SCREENING RECOMMENDATIONS ON RACIAL, ETHNIC, AND SEX DISPARITIES IN LUNG CANCER SCREENING ELIGIBILITY
Chest
Manful A, Amanna N, Park SL, Petrick JL, Rosenberg L, Tindle H, Palmer J, Wilkens L, Le Marchand L, Aldrich MC, Blume JD
doi: 10.1016/j.chest.2026.01.006
Lung Cancer
Updates in Lung Cancer Screening: A Decade of Evidence
Semin Respir Crit Care Med
Sakoda L, Henderson L
doi: 10.1055/a-2701-9312
Lung Cancer
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)
Lung Cancer
Phillips WJ, Zhan LJ, Chowdhury D, Gill J, Sun A, Rittberg R, Cohen V, Gibson AJW, Yan M, Liwski D, Surapaneni S, D'Amours MF, Yu FPS, Kim Y, Qadeer RA, Dawe DE, Agulnik J, Navani V, Fung AS, Snow S, Kuruvilla S, Ho C, Lok BH, Liu G, Wheatley-Price P, Moore S
doi: 10.1016/j.lungcan.2025.108840
Lung Cancer
Lung Cancer Screening Adherence in Centralized versus Decentralized Screening Programs A Meta-Analysis of U.S. Cohort Studies Among Individuals with Negative Baseline Results
Chest
Ezenwankwo E, Jones C, Nguyen DT, Eberth JM
doi: 10.1016/j.chest.2025.04.033
Lung Cancer
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets
Sci Rep
Seyringer S, Pilz MJ, Al-Naesan I, King MT, Bottomley A, Norman R, Schlosser L, Hell T, Gamper EM, EORTC Quality of Life Group
doi: 10.1038/s41598-024-83861-y
RECOMMENDED
Lung Cancer
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De la Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T
doi: 10.1016/j.lungcan.2025.108671
Lung Cancer
Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer
Lung Cancer
Desai RK, Zhou EJ, Chan KKW
doi: 10.1016/j.lungcan.2025.108812
RECOMMENDED
Lung Cancer
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
ESMO Open
Meyer ML, Peters S, Jänne PA, Mok TS, Bunn PA, Abdel Karim N, Altorki NK, Arrieta O, Bar J, Cappuzzo F, Carbone D, Dacic S, Diehn M, Dziadziuszko R, Felip E, Flores R, Florez N, Forde PM, Gainor JF, Gray JE, Gros L, Halmos B, Henschke CI, Herbst R, Heymach JV, Kelly K, Kris MG, Leighl NB, Mathias C, Marron TU, Mulshine JL, Naidoo J, Osarogiagbon R, Passaro A, Peled N, Planchard D, Politi K, Popat S, Pyenson B, Reckamp KL, Ren SH, Riely GJ, Rolfo C, Rudin CM, Sen T, Shields MD, Singh H, Skoulidis F, Solomon BJ, Stahel R, Stiles BM, Syrigos K, Yang JC, Yang PC, Wolf A, Wozniak AJ, Waqar SN, Wakelee H, Hirsch FR
doi: 10.1016/j.esmoop.2025.106034